4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-359676
Chief Medical Officer acquired 22,807 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bedrosian Camille L Chief Medical Officer | 2026-08-18 | Grant or award | +22,807 | 288,092 | D: show line 1 in the form |
Loading xslF345X06/ownership.xml…